You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
First-in-class TREM-1 inhibitors in combination therapy for pancreatic cancer
SBC: SIGNABLOK, INC. Topic: 102Project Summary/Abstract Carcinoma of the pancreas, or pancreatic cancer (PC), is the third leading cause of cancer-related death in the US. Despite recent advances in the current treatments that include surgery, radiation therapy, chemo- and immunotherapy, the 5-year survival rate is as low as 9%. The long-term goal of this project is to develop a first-in-class, efficient and well tolerable ther ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
SBIR Phase II: Laser-Enabled Massively Parallel Die Transfer for microLED Displays
SBC: Uniqarta, Inc. Topic: PHThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to enable a new display technology that, among other benefits, reduces the power consumption associated with public displays, TVs, mobile devices, wearables. MicroLED display technology has the potential to reduce display power consumption by 90% relative to today's displays, representing ...
SBIR Phase II 2019 National Science Foundation -
SBIR Phase II: Human Like Robotic Grippers Using Electroactive Polymers
SBC: RAS LABS, INC. Topic: BMThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be the development of a durable artificial material capable of life-like motion, contracting and expanding like human muscle when controlled by low voltage (12-volt batteries). This material also will replicate human grasp by sensing mechanical pressure across a dynamic range, from gentl ...
SBIR Phase II 2019 National Science Foundation -
SBIR Phase II: Trident Bathymetry Mapping System: A Three-Pronged Automated Solution to Satellite Derived Shallow Seafloor Surveying
SBC: TCARTA MARINE LLC Topic: MIThe broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to address the lack of advanced maps of shallow water zones, or littoral zones, crucial to global ecology and economy. An estimated 70% of the world's littoral zone is not mapped to modern standards, and traditional methods of mapping these areas are prohibitively expensive and danger ...
SBIR Phase II 2019 National Science Foundation -
Autonomous Detection and Healing of Silent Vulnerabilities
SBC: BLUERISC INC Topic: HSB0142002BlueRISC's proposed solution provides a fundamentally new approach to automated embedded software/firmware analysis relying on a novel cross-binary/firmware differential exploitability analysis framework. The solution is able to identify newly added potentially exploitable paths associated with zero/n-day vulnerabilities, characterize new functionality with respect to its potentially malicious nat ...
SBIR Phase II 2019 Department of Homeland Security -
Highly Multiplexed Nanoscale Mass Spectrometric Imaging of Cancer Tissues
SBC: AMBERGEN, INC Topic: NCISummary/Abstract Mass spectrometry (MS) has played a leading role in the past three decades in the field of proteomics. A combination of innovative MS-based techniques has provided powerful tools for proteomic discovery including the ability to identify protein biomarkers in a complex sample, quantify changes in protein expression and characterize protein- protein interactions. A second important ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
A Green Rooftop System for Commercial Buildings with Superior Energy Efficiency
SBC: XIMAX Technologies Corporation Ltd Topic: 18NCERP2This proposed Small Business Innovative Research (SBIR) Phase II project is to develop, prototype and commercialize a Green Rooftop Technology with superior building energy efficiency to significantly reduce energy consumption of our nation’s industrial and commercial buildings. Besides, this proposed technology can significantly extend the lifespan of current building rooftop materials to ...
SBIR Phase II 2019 Environmental Protection Agency -
Advanced Cooling Technologies for Multifunctional Information Distribution System (MIDS) Terminals
SBC: Roccor, LLC Topic: N172137The next generation Multifunctional Information Distribution System Joint Tactical Radio System (MIDS JTRS) is currently undergoing an upgrade to integrate new Tactical Targeting Network Technology (TTNT) capabilities. The high-power processors required generate more heat than previous shop replaceable units (SRUs). The upgraded MIDS JTRS radio terminal will generate up to approximately 30% higher ...
SBIR Phase II 2019 Department of DefenseNavy -
Stable Glucagon for Treatment of Hyperinsulinism
SBC: AMIDEBIO, LLC Topic: 200In severe persistent hyperinsulinism (HI), repeated hypoglycemic episodes can ultimately lead to permanent seizure disorders, learning disabilities, cerebral palsy, blindness and even death. Clinical studies have demonstrated the effectiveness of both short-term and long-term treatment with glucagon for severe forms of HI and continuous subcutaneous administration of glucagon has been recommended ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health -
An automated test for gestational diabetes based on glycated CD59
SBC: Mellitus, LLC Topic: 200Diabetes and pre-Diabetes are growing at an epidemic rate. Mellitus, LLC is developing a novel test for Gestational Diabetes (GDM) and Diabetes based on the novel biomarker, Glycated CD59 (GCD59), licensed exclusively to Mellitus from Harvard University. With nearly 4M annual pregnancies in the US and 130MM live births worldwide, GDM is a high public health priority because it is a major cause of ...
SBIR Phase II 2019 Department of Health and Human ServicesNational Institutes of Health